Royal Jelly and Propolis for Heart Disease
Part of Heart & circulation clinical trials.
This study tests whether royal jelly and propolis (natural bee products) can reduce inflammation and improve heart health in people with coronary artery disease (clogged heart arteries). Researchers will measure changes in blood markers and heart function over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with coronary artery disease (confirmed by heart imaging or stress test)
- Your condition is stable—you have no chest pain, or only mild chest pain with activity
- If you've had a heart attack or major event, it was more than one year ago
- You do not have advanced kidney disease (measured by creatinine clearance)
- You do not have an autoimmune disease (like rheumatoid arthritis or lupus)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two bee products—propolis and royal jelly—can help reduce inflammation and stress in the body of people with high blood pressure. Researchers want to see if adding these supplements to your current blood pressure medication helps control the condition better.
This study tests whether ginger supplements can reduce inflammation and oxidative stress (cellular damage) in people with coronary artery disease (narrowed heart arteries). Researchers want to see if ginger might help protect heart health and reduce symptoms.
This study tests if taking royal jelly, a natural substance made by bees, can reduce inflammation and stress in the body for people with high blood pressure (stage 1). It may help control blood pressure better.
This study tests whether red propolis, a natural bee product, might help slow kidney disease progression in people with moderate to advanced chronic kidney disease who aren't yet on dialysis. Researchers believe its anti-inflammatory properties could support kidney health.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This study tests whether a medication called icosapent ethyl (a purified fish oil) can help reduce plaque buildup in heart arteries and lower inflammation in people with heart disease. Researchers will use imaging and blood tests to see if it protects your heart.
Hear when a new Oxidative Stress trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.